Effect and Safety of TCM-FMD in Phlegm-Dampness Type Overweight/Obesity Patients(EASTAR)
Effect and Safety of Fasting-Mimicking Diet Combined With a "Dispelling Dampness" Meal Replacement in Phlegm-Dampness Type Overweight/Obesity Patients: A Randomized Controlled Study(EASTAR)
1 other identifier
interventional
60
1 country
1
Brief Summary
The primary aim of this study is to is to determine if a diet (TCM-FMD) which combine fasting-mimicking diet (FMD) with "dispelling dampness" meal replacement (a meal replacement made up of traditional Chinese medicine) is the effective dietary strategy for treatment of phlegm-dampness type overweight/obese patients. A three months randomized trial will be used to observe weight loss generated by TCM-FMD and FMD. And a group keeping a normal diet will be set as a blank control. Through comparison, we aim at examining the effects of interventions on weight and metabolic disease risk factors (plasma lipids, fasting glucose, blood pressure) The secondary aim of this study is to evaluate the safety of TCM-FMD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 obesity
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 21, 2019
CompletedFirst Submitted
Initial submission to the registry
July 20, 2019
CompletedFirst Posted
Study publicly available on registry
July 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 29, 2021
CompletedJuly 13, 2021
July 1, 2021
1.3 years
July 20, 2019
July 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body weight
Measuring the fasting weight of the day at the required time point and measured by the same instrument
Change from baseline to day 6/week 4/week 12
Secondary Outcomes (3)
Triglycerides
Change from baseline to week 4/week 12
Fasting glucose
Change from baseline to week 4/week 12
Blood pressure
Change from baseline to week 4/week 12
Study Arms (3)
TCM-FMD
EXPERIMENTALApply fastening-mimicking diet combined with a "dispelling dampness" meal replacement. For the convenience of implementation, a cycle of 4 weeks. The first 5 days of each cycle is the calorie restriction stage (daily calorie about 800kcal). The traditional Chinese medicine with dampness effect is used as the main source of calories in this stage. The normal diet is carried out under the guidance of a professional dietitian for the next 23 days. Study for 12 weeks.
FMD
ACTIVE COMPARATORA "grain package" is used to replace the "dispelling dampness" meal replacement, and the other thing is the same as the proposal in TCM-FMD.
Normal diet
NO INTERVENTIONCarrying out normal diet under the guidance of a dietitian, for 12 weeks.
Interventions
Apply fastening-mimicking diet combined with a "dispelling dampness" meal replacement. For the convenience of implementation, a cycle of 4 weeks. The first 5 days of each cycle is the calorie restriction stage (daily calorie about 800kcal). The traditional Chinese medicine with dampness effect is used as the main source of calories in this stage. The normal diet is carried out under the guidance of a professional dietitian for the next 23 days. Study for 12 weeks.
A "grain package" is used to replace the "dispelling dampness" meal replacement, and the other thing is the same as the proposal in TCM-FMD.
Eligibility Criteria
You may qualify if:
- Diagnosed as overweight / obesity according to the "China Adult Obesity Prevention and Treatment Expert Consensus"
- Diagnosis as phlegm-dampness type according to the "Traditional Chinese Medicine Classification and Judgment" scale published by the Chinese Medicine Association
- years old ≤ age ≤ 65 years old
- Signed the informed consent
You may not qualify if:
- Those who have special food requirements or having a history of food allergies
- Those who have history of previous diabetes, or body weight loss, BMI ≤ 18
- Those who have had cardiovascular and cerebrovascular events within half a year, or who have a major history of surgery
- Pregnant or lactating woman
- Those who have severe primary diseases such as liver or kidney diseases, as well as abnormalities in the hematopoietic system and mental disorders
- Those who need to take special drugs (such as hormones)
- Those who refuse to provide information required for research (such as personal information, blood samples, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, 510000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yuanqi Zhao, MD
Guangdong Provincial Hospital of Traditional Chinese Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
July 20, 2019
First Posted
July 23, 2019
Study Start
June 21, 2019
Primary Completion
September 30, 2020
Study Completion
March 29, 2021
Last Updated
July 13, 2021
Record last verified: 2021-07